M1 Kliniken AG (FRA:M12)
Germany flag Germany · Delayed Price · Currency is EUR
16.74
-0.26 (-1.53%)
At close: Jan 30, 2026

M1 Kliniken AG Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
354.98339.18316.32285.29314.61159.59
Revenue Growth (YoY)
6.51%7.23%10.88%-9.32%97.14%106.68%
Cost of Revenue
307.41295.76283.85254.06281.89139.79
Gross Profit
47.5743.4232.4731.2332.7219.8
Selling, General & Admin
2.342.341.981.661.671.85
Other Operating Expenses
10.459.819.8214.5713.239.07
Operating Expenses
18.0217.3717.1122.2920.5915.4
Operating Income
29.5526.0515.378.9412.144.4
Interest Expense
-1.83-1.93-1.35-0.83-0.92-0.72
Interest & Investment Income
1.030.992.11.51.870.3
Earnings From Equity Investments
-----1.92
Currency Exchange Gain (Loss)
0.230.23-0.07-0.07-0.3-0.18
Other Non Operating Income (Expenses)
0.370.370.010.260.040.01
EBT Excluding Unusual Items
29.3525.7116.069.8112.845.73
Gain (Loss) on Sale of Investments
-1.290.48-00.221.33-1.83
Gain (Loss) on Sale of Assets
0.070.070.240.010.01-0.35
Other Unusual Items
-----5.08
Pretax Income
28.1626.316.4510.2314.428.78
Income Tax Expense
8.48.514.783.163.541.35
Earnings From Continuing Operations
19.7617.7911.677.0710.887.42
Minority Interest in Earnings
-2.02-1.77-1.39-2.75-1.97-0.6
Net Income
17.7416.0210.274.328.916.82
Net Income to Common
17.7416.0210.274.328.916.82
Net Income Growth
5.87%55.91%137.98%-51.52%30.52%-29.87%
Shares Outstanding (Basic)
191919181919
Shares Outstanding (Diluted)
191919181919
Shares Change (YoY)
1.34%-1.82%4.43%-1.43%-0.02%6.19%
EPS (Basic)
0.950.850.540.240.480.37
EPS (Diluted)
0.950.850.540.240.480.37
EPS Growth
4.47%58.79%127.89%-50.82%30.54%-33.96%
Free Cash Flow
34.8630.327.3519.6114.668.63
Free Cash Flow Per Share
1.871.610.391.070.790.47
Dividend Per Share
0.5000.5000.500---
Gross Margin
13.40%12.80%10.27%10.95%10.40%12.41%
Operating Margin
8.33%7.68%4.86%3.14%3.86%2.76%
Profit Margin
5.00%4.72%3.25%1.51%2.83%4.28%
Free Cash Flow Margin
9.82%8.94%2.33%6.87%4.66%5.41%
EBITDA
30.9627.4516.9210.614.425.72
EBITDA Margin
8.72%8.09%5.35%3.71%4.58%3.58%
D&A For EBITDA
1.41.391.551.652.291.32
EBIT
29.5526.0515.378.9412.144.4
EBIT Margin
8.33%7.68%4.86%3.14%3.86%2.76%
Effective Tax Rate
29.83%32.35%29.06%30.91%24.57%15.41%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.